Download PDF
Thromb Haemost 2025; 125(07): 697-712
DOI: 10.1055/a-2437-6111
Atherosclerosis and Ischaemic Disease

Characterization of CD3+ T Lymphocytes in Human Coronary Thrombi with ST-segment Elevation Myocardial Infarction

Muyang Gu   *
1   Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2   Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
3   Hubei Provincial Engineering Research Center of Immunological Diagnosis and Therapy for Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
,
Ni Xia   *
1   Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2   Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
3   Hubei Provincial Engineering Research Center of Immunological Diagnosis and Therapy for Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
,
Si Zhang
1   Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2   Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
3   Hubei Provincial Engineering Research Center of Immunological Diagnosis and Therapy for Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
,
Xinyu Zhu
1   Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2   Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
3   Hubei Provincial Engineering Research Center of Immunological Diagnosis and Therapy for Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
,
Meilin Liu
1   Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2   Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
3   Hubei Provincial Engineering Research Center of Immunological Diagnosis and Therapy for Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
,
Yuzhi Lu
1   Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2   Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
3   Hubei Provincial Engineering Research Center of Immunological Diagnosis and Therapy for Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
,
Nana Li
1   Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2   Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
3   Hubei Provincial Engineering Research Center of Immunological Diagnosis and Therapy for Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
,
Haoyi Yang
1   Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2   Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
3   Hubei Provincial Engineering Research Center of Immunological Diagnosis and Therapy for Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
,
Tingting Tang
1   Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2   Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
3   Hubei Provincial Engineering Research Center of Immunological Diagnosis and Therapy for Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
,
Shaofang Nie
1   Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2   Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
3   Hubei Provincial Engineering Research Center of Immunological Diagnosis and Therapy for Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
,
Jingyong Li
1   Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2   Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
3   Hubei Provincial Engineering Research Center of Immunological Diagnosis and Therapy for Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
,
Fen Yang
1   Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2   Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
3   Hubei Provincial Engineering Research Center of Immunological Diagnosis and Therapy for Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
,
Jiao Jiao
1   Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2   Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
3   Hubei Provincial Engineering Research Center of Immunological Diagnosis and Therapy for Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
,
Bingjie Lv
1   Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2   Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
3   Hubei Provincial Engineering Research Center of Immunological Diagnosis and Therapy for Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
,
Weimin Wang
4   Department of Immunology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
,
Desheng Hu
5   Department of Integrated Traditional Chinese and Western Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
,
Jiong Hu
6   Department of Histology and Embryology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
,
Huirong Liu
7   Department of Physiology & Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing, China
,
Chen Chen
8   Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
,
Xiang Cheng
1   Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2   Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
3   Hubei Provincial Engineering Research Center of Immunological Diagnosis and Therapy for Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
› Author Affiliations
Funding This work was supported by grants from the National Natural Science Foundation of China [No. 82030016 and 82230011 to X.C.; No. 82200320 to M.G.; No. 82170282 to N.X.; No. 82000443 to J.L.].
› Further Information
   Permissions and Reprints


Abstract

Background The occurrence and development of ST-segment elevation myocardial infarction (STEMI) are accompanied by coronary atherothrombosis and occlusion, and immune responses play prominent roles in their pathogeneses. However, the causes of atherothrombosis remain elusive, and a comprehensive study of T cell-mediated immune responses in coronary thrombi from STEMI patients is lacking.

Objectives The aim of this study was to determine the heterogeneity and clonality of CD3+ T lymphocytes in STEMI patients at the single-cell level.

Methods Paired single-cell RNA and T cell receptor (TCR) sequencing was performed on CD3+ T lymphocytes in the coronary thrombi and peripheral blood of STEMI patients, as well as the blood from control subjects without coronary artery disease (CAD).

Results Compared with those in the peripheral blood of STEMI patients, the activation, cytotoxicity, proinflammatory, and prothrombotic characteristics of CD3+ T lymphocytes in coronary thrombi were decreased, and the clonality of CD3+ T cells was increased. Compared with those from non-CAD controls, T lymphocytes from STEMI patients exhibited an upregulation of genes related to recent TCR engagement, suggesting antigen-specific stimulation in STEMI. Antigen specificity prediction using an algorithm indicated the probability of T cells from different patients binding to similar antigens for clonal expansion during STEMI.

Conclusion This study provides a basis for exploring the cellular heterogeneity of CD3+ T lymphocytes in the coronary thrombi and peripheral blood of STEMI patients. Identifying the precise adaptive immune mechanisms driving atherothrombosis may lead to innovative therapies that selectively target the aberrant immune response, resulting in more effective treatments for STEMI.

Keyword

STEMI - T lymphocyte - coronary thrombosis - platelets - T cell receptors

Authors' Contribution

M.G., N.X., and X.C. designed the study. M.G., N.X., Y.L., S.N., and J.J. enrolled participants and supervised study participant recruitment. M.G., X.Z., M.L., N.L., and H.Y. collected the samples and performed the experiments. M.G., S.Z., and T.T. designed and performed the analysis. M.G. and N.X. prepared the manuscript and the figures. N.X., X.C., J.L., F.Y., B.L., H.L., and C.C. edited and revised the manuscript. X.C., W.W., D.H., and J.H. supervised the project. All the authors contributed to the interpretation of the results and the composition of the final manuscript. All the authors have read and approved the final version of the paper.


* These authors contributed equally to this work.


Supplementary Material



Publication History

Received: 28 February 2024

Accepted: 09 October 2024

Article published online:
07 November 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Interpretation of the annual report on cardiovascular health and diseases in China 2021. Cardiol Discov 2023; 3 (04) 277-300
    Search in Google Scholar
  • 2 Sakakura K, Nakano M, Otsuka F, Ladich E, Kolodgie FD, Virmani R. Pathophysiology of atherosclerosis plaque progression. Heart Lung Circ 2013; 22 (06) 399-411
    Search in Google Scholar
  • 3 Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000; 20 (05) 1262-1275
    Search in Google Scholar
  • 4 Finn AV, Nakano M, Narula J, Kolodgie FD, Virmani R. Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc Biol 2010; 30 (07) 1282-1292
    Search in Google Scholar
  • 5 Wolf D, Ley K. Immunity and inflammation in atherosclerosis. Circ Res 2019; 124 (02) 315-327
    Search in Google Scholar
  • 6 Falk E, Nakano M, Bentzon JF, Finn AV, Virmani R. Update on acute coronary syndromes: the pathologists' view. Eur Heart J 2013; 34 (10) 719-728
    Search in Google Scholar
  • 7 Tabas I. Macrophage apoptosis in atherosclerosis: consequences on plaque progression and the role of endoplasmic reticulum stress. Antioxid Redox Signal 2009; 11 (09) 2333-2339
    Search in Google Scholar
  • 8 Klingenberg R, Brokopp CE, Grivès A. et al. Clonal restriction and predominance of regulatory T cells in coronary thrombi of patients with acute coronary syndromes. Eur Heart J 2015; 36 (17) 1041-1048
    Search in Google Scholar
  • 9 Lin YZ, Lu SH, Lu ZD. et al. Downregulation of CD4+LAP+ and CD4+CD25+ regulatory T cells in acute coronary syndromes. Mediators Inflamm 2013; 2013: 764082
    Search in Google Scholar
  • 10 Witztum JL, Lichtman AH. The influence of innate and adaptive immune responses on atherosclerosis. Annu Rev Pathol 2014; 9: 73-102
    Search in Google Scholar
  • 11 Matsuura E, Atzeni F, Sarzi-Puttini P, Turiel M, Lopez LR, Nurmohamed MT. Is atherosclerosis an autoimmune disease?. BMC Med 2014; 12: 47
    Search in Google Scholar
  • 12 Chistiakov DA, Orekhov AN, Bobryshev YV. Immune-inflammatory responses in atherosclerosis: role of an adaptive immunity mainly driven by T and B cells. Immunobiology 2016; 221 (09) 1014-1033
    Search in Google Scholar
  • 13 Liuzzo G, Goronzy JJ, Yang H. et al. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation 2000; 101 (25) 2883-2888
    Search in Google Scholar
  • 14 Flego D, Liuzzo G, Weyand CM, Crea F. Adaptive immunity dysregulation in acute coronary syndromes: from cellular and molecular basis to clinical implications. J Am Coll Cardiol 2016; 68 (19) 2107-2117
    Search in Google Scholar
  • 15 Papalexi E, Satija R. Single-cell RNA sequencing to explore immune cell heterogeneity. Nat Rev Immunol 2018; 18 (01) 35-45
    Search in Google Scholar
  • 16 Winkels H, Ehinger E, Vassallo M. et al. Atlas of the immune cell repertoire in mouse atherosclerosis defined by single-cell RNA-sequencing and mass cytometry. Circ Res 2018; 122 (12) 1675-1688
    Search in Google Scholar
  • 17 Cole JE, Park I, Ahern DJ. et al. Immune cell census in murine atherosclerosis: cytometry by time of flight illuminates vascular myeloid cell diversity. Cardiovasc Res 2018; 114 (10) 1360-1371
    Search in Google Scholar
  • 18 Cochain C, Vafadarnejad E, Arampatzi P. et al. Single-cell RNA-seq reveals the transcriptional landscape and heterogeneity of aortic macrophages in murine atherosclerosis. Circ Res 2018; 122 (12) 1661-1674
    Search in Google Scholar
  • 19 Lin JD, Nishi H, Poles J. et al. Single-cell analysis of fate-mapped macrophages reveals heterogeneity, including stem-like properties, during atherosclerosis progression and regression. JCI Insight 2019; 4 (04) e124574
    Search in Google Scholar
  • 20 Fernandez DM, Rahman AH, Fernandez NF. et al. Single-cell immune landscape of human atherosclerotic plaques. Nat Med 2019; 25 (10) 1576-1588
    Search in Google Scholar
  • 21 Depuydt MAC, Prange KHM, Slenders L. et al. Microanatomy of the human atherosclerotic plaque by single-cell transcriptomics. Circ Res 2020; 127 (11) 1437-1455
    Search in Google Scholar
  • 22 Chowdhury RR, D'Addabbo J, Huang X. et al. Human coronary plaque T cells are clonal and cross-react to virus and self. Circ Res 2022; 130 (10) 1510-1530
    Search in Google Scholar
  • 23 Depuydt MAC, Schaftenaar FH, Prange KHM. et al. Single-cell T cell receptor sequencing of paired human atherosclerotic plaques and blood reveals autoimmune-like features of expanded effector T cells. Nat Cardiovasc Res 2023; 2 (02) 112-125
    Search in Google Scholar
  • 24 Wang Z, Zhang X, Lu S. et al. Pairing of single-cell RNA analysis and T cell antigen receptor profiling indicates breakdown of T cell tolerance checkpoints in atherosclerosis. Nat Cardiovasc Res 2023; 2 (03) 290-306
    Search in Google Scholar
  • 25 Ramaiola I, Padró T, Peña E. et al. Changes in thrombus composition and profilin-1 release in acute myocardial infarction. Eur Heart J 2015; 36 (16) 965-975
    Search in Google Scholar
  • 26 Stuart T, Butler A, Hoffman P. et al. Comprehensive integration of single-cell data. Cell 2019; 177 (07) 1888-1902.e21
    Search in Google Scholar
  • 27 Butler A, Hoffman P, Smibert P, Papalexi E, Satija R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol 2018; 36 (05) 411-420
    Search in Google Scholar
  • 28 Zhang L, Yu X, Zheng L. et al. Lineage tracking reveals dynamic relationships of T cells in colorectal cancer. Nature 2018; 564 (7735) 268-272
    Search in Google Scholar
  • 29 Gaydosik AM, Tabib T, Domsic R, Khanna D, Lafyatis R, Fuschiotti P. Single-cell transcriptome analysis identifies skin-specific T-cell responses in systemic sclerosis. Ann Rheum Dis 2021; 80 (11) 1453-1460
    Search in Google Scholar
  • 30 Aran D, Looney AP, Liu L. et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat Immunol 2019; 20 (02) 163-172
    Search in Google Scholar
  • 31 Herder C, Peeters W, Illig T. et al; CARDIoGRAM Consortium. RANTES/CCL5 and risk for coronary events: results from the MONICA/KORA Augsburg case-cohort, Athero-Express and CARDIoGRAM studies. PLoS One 2011; 6 (12) e25734
    Search in Google Scholar
  • 32 Mirabelli-Badenier M, Braunersreuther V, Viviani GL. et al. CC and CXC chemokines are pivotal mediators of cerebral injury in ischaemic stroke. Thromb Haemost 2011; 105 (03) 409-420
    Search in Google Scholar
  • 33 Najem MY, Couturaud F, Lemarié CA. Cytokine and chemokine regulation of venous thromboembolism. J Thromb Haemost 2020; 18 (05) 1009-1019
    Search in Google Scholar
  • 34 Cenerenti M, Saillard M, Romero P, Jandus C. The era of cytotoxic CD4 T cells. Front Immunol 2022; 13: 867189
    Search in Google Scholar
  • 35 Serroukh Y, Gu-Trantien C, Hooshiar Kashani B. et al. The transcription factors Runx3 and ThPOK cross-regulate acquisition of cytotoxic function by human Th1 lymphocytes. eLife 2018; 7: 7
    Search in Google Scholar
  • 36 Tavakolian Ferdousie V, Mohammadi M, Hassanshahi G. et al. Serum CXCL10 and CXCL12 chemokine levels are associated with the severity of coronary artery disease and coronary artery occlusion. Int J Cardiol 2017; 233: 23-28
    Search in Google Scholar
  • 37 Leberzammer J, Agten SM, Blanchet X. et al. Targeting platelet-derived CXCL12 impedes arterial thrombosis. Blood 2022; 139 (17) 2691-2705
    Search in Google Scholar
  • 38 Dominguez-Villar M, Hafler DA. Regulatory T cells in autoimmune disease. Nat Immunol 2018; 19 (07) 665-673
    Search in Google Scholar
  • 39 Pita-López ML, Pera A, Solana R. Adaptive memory of human NK-like CD8+ T-cells to aging, and viral and tumor antigens. Front Immunol 2016; 7: 616
    Search in Google Scholar
  • 40 Wang J, Xu Y, Chen Z. et al. Liver immune profiling reveals pathogenesis and therapeutics for biliary atresia. Cell 2020; 183 (07) 1867-1883.e26
    Search in Google Scholar
  • 41 Shugay M, Bagaev DV, Zvyagin IV. et al. VDJdb: a curated database of T-cell receptor sequences with known antigen specificity. Nucleic Acids Res 2018; 46 (D1): D419-D427
    Search in Google Scholar
  • 42 Tickotsky N, Sagiv T, Prilusky J, Shifrut E, Friedman N. McPAS-TCR: a manually curated catalogue of pathology-associated T cell receptor sequences. Bioinformatics 2017; 33 (18) 2924-2929
    Search in Google Scholar
  • 43 Bending D, Zikherman J. Nr4a nuclear receptors: markers and modulators of antigen receptor signaling. Curr Opin Immunol 2023; 81: 102285
    Search in Google Scholar
  • 44 Glanville J, Huang H, Nau A. et al. Identifying specificity groups in the T cell receptor repertoire. Nature 2017; 547 (7661) 94-98
    Search in Google Scholar
  • 45 Kwong JC, Schwartz KL, Campitelli MA. et al. Acute myocardial infarction after laboratory-confirmed influenza infection. N Engl J Med 2018; 378 (04) 345-353
    Search in Google Scholar
  • 46 Warren-Gash C, Hayward AC, Hemingway H. et al. Influenza infection and risk of acute myocardial infarction in England and Wales: a CALIBER self-controlled case series study. J Infect Dis 2012; 206 (11) 1652-1659
    Search in Google Scholar
  • 47 Kimura T, Tse K, Sette A, Ley K. Vaccination to modulate atherosclerosis. Autoimmunity 2015; 48 (03) 152-160
    Search in Google Scholar
  • 48 Rossmann A, Henderson B, Heidecker B. et al. T-cells from advanced atherosclerotic lesions recognize hHSP60 and have a restricted T-cell receptor repertoire. Exp Gerontol 2008; 43 (03) 229-237
    Search in Google Scholar
  • 49 Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 2006; 6 (07) 508-519
    Search in Google Scholar
  • 50 Pessi T, Karhunen V, Karjalainen PP. et al. Bacterial signatures in thrombus aspirates of patients with myocardial infarction. Circulation 2013; 127 (11) 1219-1228 , e1–e6
    Search in Google Scholar